Summit Securities Group’s Labcorp LH Stock Holding History

Summit Securities Group’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.73K	Sell	14 -108	-89%	-$29.2K	﹤0.01%	847
2025 Q4	$30.6K	Sell	122 -23	-16%	-$6.11K	﹤0.01%	720
2025 Q3	$41.6K	Buy	145 +89	+159%	+$23.8K	0.01%	610
2025 Q2	$14.7K	Buy	+56	New	+$13.6K	﹤0.01%	803
2023 Q3	–	Sell	-135	Closed	-$28K	–	820
2023 Q2	$28K	Sell	135 -68	-33%	-$13.2K	﹤0.01%	551
2023 Q1	$40K	Buy	203 +98	+93%	+$20.2K	﹤0.01%	472
2022 Q4	$21K	Buy	105 +85	+425%	+$16.6K	﹤0.01%	894
2022 Q3	$3K	Sell	20 -206	-91%	-$42.2K	﹤0.01%	849
2022 Q2	$45K	Buy	226 +182	+414%	+$38.8K	0.01%	578
2022 Q1	$10K	Buy	+44	New	+$10.3K	﹤0.01%	840
2015 Q4	–	Sell	-19	Closed	-$2K	–	376
2015 Q3	$2K	Buy	+19	New	+$1.97K	﹤0.01%	310

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Summit Securities Group's LH Position: Q1 2026 in Review

Summit Securities Group reduced its Labcorp (LH) stake by 89% in Q1 2026, selling an estimated $29.2K and leaving 14 shares worth $3.73K. The position accounts for ﹤0.01% of the portfolio, ranked #847.

Summit Securities Group first reported a position in LH in Q3 2015 and has held it in 11 quarters since. The position peaked at $45K in Q2 2022. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

Summit Securities Group held 14 shares of Labcorp worth $3.73K as of Q1 2026.
Summit Securities Group sold 108 Labcorp shares in Q1 2026, an estimated $29.2K.
Labcorp made up ﹤0.01% of Summit Securities Group's portfolio in Q1 2026, its #847 holding.
Summit Securities Group first reported a position in Labcorp in Q3 2015 and has held it in 11 quarters since.
Summit Securities Group's Labcorp position peaked at $45K in Q2 2022.
1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Summit Securities Group's 13F filing for Q1 2026, filed 30 Apr 2026.